Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 1/20 | 0.79 |
| ▸ | MAPT | P10636 | 4/20 | 0.75 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.75 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.75 |
| ▸ | GAA | P10253 | 1/20 | 0.75 |
| ▸ | XBP1 | P17861 | 1/20 | 0.75 |
| ▸ | ELANE | P08246 | 2/20 | 0.72 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.51 |
| ▸ | MEN1 | O00255 | 3/20 | 0.48 |
| ▸ | HTT | P42858 | 2/20 | 0.47 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | F3 | P13726 | 1/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.45 |
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5042773 | 1.00 | CYP2C19 (0.79) | CYP2C19MAPTNPSR1KDM4EGAA | |
| SCHEMBL29583383 | 0.89 | CYP2C19 (0.80) | CYP2C19MAPTNPSR1KDM4EGAA | |
| SCHEMBL29690272 | 0.89 | CYP2C19 (0.80) | CYP2C19MAPTNPSR1KDM4EGAA | |
| SCHEMBL5048033 | 0.89 | CYP2C19 (0.80) | CYP2C19MAPTNPSR1KDM4EGAA | |
| SCHEMBL5048036 | 0.89 | CYP2C19 (0.80) | CYP2C19MAPTNPSR1KDM4EGAA | |
| SCHEMBL31211469 | 0.89 | CYP2C19 (0.80) | CYP2C19MAPTNPSR1KDM4EGAA | |
| SCHEMBL16710294 | 0.88 | CYP2C19 (1.00) | CYP2C19MAPTNPSR1KDM4EGAA | |
| SCHEMBL8925834 | 0.88 | CYP2C19 (1.00) | CYP2C19MAPTNPSR1KDM4EGAA | |
| SCHEMBL28551481 | 0.88 | CYP2C19 (1.00) | CYP2C19MAPTNPSR1KDM4EGAA | |
| SCHEMBL4237838 | 0.88 | CYP2C19 (1.00) | CYP2C19MAPTNPSR1KDM4EGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7425320-B2 | Use of guaiol for treating the skin | CIBA SPECIALTY CHEMICALS CORP (US) | 2008-09-16 | — | — | US | disclosed |
| US-20050058610-A1 | Cosmetic mixtures containing ultraviolet radiation absorber and decoloring agents | CIBA SPECIALTY CHEMICALS CORP. | 2005-03-17 | — | — | US | disclosed |
| EP-1432400-A1 | USE OF GUAIOL FOR TREATING THE SKIN | Ciba SC Holding AG (CH) | 2004-06-30 | — | — | EP | disclosed |
| WO-2003024417-A1 | USE OF GUAIOL FOR TREATING THE SKIN | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2003-03-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050058610-A1 | Cosmetic mixtures containing ultraviolet radiation absorber and decoloring agents | TYR, MC1R, UNG | CYP2C19 688/4885MAPT 673/4885NPSR1 2582/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.